MKI67 and carcinoma: Ki-67 nuclear chromatin immunostaining differed between carcinomas and neuroendocrine tumor specimens, suggesting that NG can be effortlessly identified and categorized in different neoplasias in which genetic changes result in cellular heterogeneity.